• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings

    6/18/25 2:04:00 PM ET
    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Other Consumer Services
    Real Estate
    Get the next $EYEN alert in real time by email

    NEW YORK, June 18, 2025 /PRNewswire/ -- Chardan, a leading global investment banking and advisory firm, today announced an expansion into the digital asset sector, advising on and structuring a series of transactions that bridge traditional capital markets with the rapidly evolving world of blockchain and cryptocurrency.

    Chardan logo (PRNewsfoto/Chardan)

    As part of its strategic push into crypto finance, Chardan has recently served as a strategic advisor and placement agent in the following notable transactions:

    Eyenovia's $50 Million PIPE to Acquire HYPE Tokens

    Chardan acted as sole placement agent in Eyenovia Inc.'s (NASDAQ:EYEN) $50 million PIPE financing. The proceeds are being used to acquire over 1 million HYPE tokens, the native asset of the Hyperliquid blockchain, making Eyenovia the first U.S.-listed company to hold HYPE in its treasury.

    This transaction positions Eyenovia as a top validator on the Hyperliquid network and includes a strategic staking initiative in partnership with Anchorage Digital. The financing involved the issuance of non-voting convertible preferred stock and warrants, potentially raising up to $150 million in total proceeds.

    Lion Group's $600 Million Facility to Launch Hyperliquid Strategy

    Chardan acted as sole placement agent in Lion Group Holding's (NASDAQ:LGHL) $600 million facility. The facility supports the strategic accumulation of HYPE as a reserve asset, alongside Solana (SOL) and Sui (SUI). This represents LGHL's relaunch of crypto operations and its pivot toward decentralized finance infrastructure.

    VivoPower's $121 Million PIPE to Launch XRP Treasury Strategy

    Chardan acted as placement agent for the $121 million private placement for VivoPower International PLC (NASDAQ:VVPR). VivoPower is believed to be the first public company to implement an XRP-focused digital asset treasury strategy. Proceeds will be used to acquire XRP, build out a decentralized finance team, and contribute to the XRPL ecosystem.

    Classover's $500 Million Convertible Notes for Solana Treasury Strategy

    Chardan served as financial advisor to Classover Holdings, Inc. (NASDAQ:KIDZ) in its $11 million initial tranche which is the first issuance under the $500 million senior secured convertible note financing.

    Under the terms of the financing agreement, approximately 80% of the net proceeds from the initial tranche will be allocated toward the purchase of Solana (SOL) tokens, subject to certain terms and limitations.

    Classover has already acquired over 6,400 SOL tokens and is exploring additional opportunities in staking and locked token acquisitions, reinforcing its commitment to blockchain-integrated financial strategy.

    Chardan's Vision for the Future of Finance

    "These transactions underscore our commitment to leading the convergence of traditional finance and digital assets," said Jonas Grossman, President and Managing Partner at Chardan. "We are proud to support visionary companies like Eyenovia, VivoPower, Classover, and Lion Group Holding as they redefine capital allocation and treasury management in the Web3 era."

    Chardan continues to expand its digital asset advisory capabilities, offering bespoke capital markets solutions, tokenomics structuring, and blockchain integration strategies for forward-thinking clients.

    About Chardan:

    Chardan is an independent global investment bank specializing in healthcare, digital assets, technology, SPACs, and emerging growth companies. Our range of services include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access, and institutional trading. Headquartered in New York City, Chardan is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: FINRA, SIPC, and NASDAQ. 

    Chardan Media Contact:

    Emily Levine

    Chief Commercial Officer

    [email protected] 

    (475) 400-6071

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/chardan-expands-into-digital-assets-by-advising-strategic-crypto-backed-financings-302485587.html

    SOURCE Chardan

    Get the next $EYEN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EYEN
    $KIDZ
    $LGHL
    $VVPR

    CompanyDatePrice TargetRatingAnalyst
    Eyenovia Inc.
    $EYEN
    11/18/2024$12.00 → $2.00Buy → Neutral
    H.C. Wainwright
    More analyst ratings

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Eyenovia downgraded by H.C. Wainwright with a new price target

    H.C. Wainwright downgraded Eyenovia from Buy to Neutral and set a new price target of $2.00 from $12.00 previously

    11/18/24 7:44:30 AM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    HC Wainwright & Co. reiterated coverage on Eyenovia with a new price target

    HC Wainwright & Co. reiterated coverage of Eyenovia with a rating of Buy and set a new price target of $8.00 from $6.00 previously

    4/1/21 6:45:58 AM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Northland Capital initiated coverage on Eyenovia with a new price target

    Northland Capital initiated coverage of Eyenovia with a rating of Outperform and set a new price target of $10.00

    3/1/21 9:11:48 AM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    SEC Filings

    View All

    SEC Form 6-K filed by Lion Group Holding Ltd.

    6-K - Lion Group Holding Ltd (0001806524) (Filer)

    9/8/25 4:30:09 PM ET
    $LGHL
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 6-K filed by Lion Group Holding Ltd.

    6-K - Lion Group Holding Ltd (0001806524) (Filer)

    9/8/25 8:30:17 AM ET
    $LGHL
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 424B3 filed by VivoPower International PLC

    424B3 - VivoPower International PLC (0001681348) (Filer)

    9/5/25 5:24:47 PM ET
    $VVPR
    Power Generation
    Utilities

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for MYDCOMBI issued to EYENOVIA INC.

    Submission status for EYENOVIA INC.'s drug MYDCOMBI (ORIG-1) with active ingredient TROPICAMIDE AND PHENYLEPHRINE HYDROCHLORIDE has changed to 'Approval' on 05/05/2023. Application Category: NDA, Application Number: 215352, Application Classification: Type 5 - New Formulation or New Manufacturer

    5/8/23 1:05:04 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Rowe Michael M bought $14,077 worth of shares (27,071 units at $0.52), increasing direct ownership by 33% to 109,998 units (SEC Form 4)

    4 - EYENOVIA, INC. (0001682639) (Issuer)

    8/28/24 8:01:36 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Rowe Michael M bought $28,500 worth of shares (50,000 units at $0.57), increasing direct ownership by 152% to 82,927 units (SEC Form 4)

    4 - EYENOVIA, INC. (0001682639) (Issuer)

    8/27/24 1:06:37 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Grant Stuart M. bought $1,000,000 worth of shares (1,515,151 units at $0.66), increasing direct ownership by 16% to 10,914,153 units (SEC Form 4)

    4 - EYENOVIA, INC. (0001682639) (Issuer)

    7/3/24 3:18:06 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Investment Officer Jung Hyunsu was granted 500,000 shares (SEC Form 4)

    4 - HYPERION DEFI, INC. (0001682639) (Issuer)

    7/9/25 4:04:50 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Jacobson Rachel was granted 5,000 shares, increasing direct ownership by 384% to 6,301 units (SEC Form 4)

    4 - HYPERION DEFI, INC. (0001682639) (Issuer)

    7/9/25 4:04:18 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Rowe Michael M was granted 6,600 shares, increasing direct ownership by 480% to 7,975 units (SEC Form 4)

    4 - HYPERION DEFI, INC. (0001682639) (Issuer)

    7/9/25 4:03:45 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VivoPower's Tembo to Accept Ripple USD (RLUSD) Stablecoin for Payments

    Tembo operates globally across markets, including Southeast Asia, Africa, and the Middle East  RLUSD is the fast-growing stablecoin established by Ripple Labs RLUSD stablecoin enables near-instant low-cost international funds transfers LONDON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ:VVPR) (the "Company") announced today that its electric vehicle subsidiary, Tembo e-LV ("Tembo"), is accepting payments from customers and partners in RLUSD, the stablecoin established by Ripple Labs ("Ripple"). As a business that operates globally across developed as well as developing nations, Tembo has been seeking practical solutions to real-life challenges that affect con

    9/8/25 8:50:00 AM ET
    $VVPR
    Power Generation
    Utilities

    Lion Group Holding Ltd. Announces Strategic Treasury Reallocation: Converting SOL and SUI Assets to Hyperliquid (HYPE) following U.S. Institutional Custody Milestone

    SINGAPORE, Sept. 8, 2025 /PRNewswire/ -- Lion Group Holding Ltd. (NASDAQ:LGHL) ("LGHL" or the "Company"), a leading operator of an all-in-one trading platform, today announced its plan to exchange all of its current Solana (SOL) and Sui (SUI) assets to Hyperliquid (HYPE). This follows the launch of institutional HYPE EVM custody solutions in the U.S. by BitGo Trust Company, Inc. ("BitGo") and aims to optimize the Company's cryptocurrency portfolio by leveraging Hyperliquid's high-performance Layer 1 blockchain and decentralized perpetual futures exchange capabilities. As part of this reallocation, LGHL will employ an accumulation strategy to convert its SOL and SUI positions into HYPE over

    9/8/25 8:30:00 AM ET
    $LGHL
    Investment Bankers/Brokers/Service
    Finance

    Mercurity Fintech's Chief Strategy Officer and Director, Wilfred Daye, Discusses Digital Asset Infrastructure and Business Objectives on Bloomberg TV's New to The Street

    New York, NY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Mercurity Fintech Holding Inc. (the "Company," "we," "us," "our company," or "MFH") (NASDAQ:MFH), a blockchain-powered fintech group and Russell 2000 Index member, today announced that Wilfred Daye, its Chief Strategy Officer (CSO) and a member of its Board of Directors, appeared on New to The Street, broadcast on Bloomberg TV on Saturday, August 30, 2025 as sponsored programming, to discuss the Company's strategic positioning and share insights on digital asset transformation. What's Driving the Change During the interview, Daye explained a trend that's quietly reshaping corporate America: companies are moving beyond just tracking earning

    9/4/25 9:00:00 AM ET
    $KIDZ
    $MFH
    $TDTH
    Other Consumer Services
    Real Estate
    Finance: Consumer Services
    Finance

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    Leadership Updates

    Live Leadership Updates

    View All

    Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

    LAGUNA HILLS, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN) ("Eyenovia" or the "Company"), a pioneer in ophthalmic technologies and the first publicly-listed U.S. company to build a strategic treasury of HYPE, the native token of the Hyperliquid protocol, today announced several key developments in support of its digital asset capital strategy. Avenue Capital Group, now the Company's largest common stockholder, has agreed to amend Eyenovia's senior secured debt to further support the Company as it builds its HYPE treasury and reserve of the HYPE token. Pursuant to the terms of the amendment, the maturity date of the debt has been extended from November 1, 2025 to

    6/18/25 8:32:42 AM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VivoPower to host Annual General Meeting on December 30, 2024 in London

    London, Dec. 06, 2024 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ:VVPR) (the "Company" or "VivoPower") is pleased to announce that it will hold its Annual General Meeting ("AGM") at its offices in London on Monday, December 30, 2024, at 1:00 p.m. London time. The resolutions to be passed include: Laying of annual accounts and reportsDirectors' remuneration reportRe-appointment of auditorsRemuneration of auditorsExtension of the term of William Langdon appointment as director of the CompanyApproval for Mergers or Divestments The formal notice of the AGM with accompanying proxy forms and dial in details will be mailed to shareholders in accordance with the statutory period pri

    12/6/24 3:42:00 PM ET
    $VVPR
    Power Generation
    Utilities

    Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer

    NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a commercial-stage ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, today announced the appointment of experienced finance and accounting executive Andrew Jones as Chief Financial Officer. Mr. Jones brings to the Eyenovia team more than 30 years of diverse finance and accounting leadership experience spanning therapeutics and medical technology/devices, most recently serving as Chief Financial Officer of NovaBay Pharmaceuticals, Inc., a publicly traded, commercial stage ophthalmic company. Eyenovia's current CFO, John Gandolfo, is retiring and will remain with

    9/3/24 7:00:00 AM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Eyenovia Inc.

    SC 13D/A - EYENOVIA, INC. (0001682639) (Subject)

    12/4/24 4:12:20 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Eyenovia Inc.

    SC 13G/A - EYENOVIA, INC. (0001682639) (Subject)

    11/14/24 5:08:44 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by VivoPower International PLC

    SC 13G/A - VivoPower International PLC (0001681348) (Subject)

    10/4/24 4:01:08 PM ET
    $VVPR
    Power Generation
    Utilities

    $EYEN
    $KIDZ
    $LGHL
    $VVPR
    Financials

    Live finance-specific insights

    View All

    LGHL Acquires Additional SUI, Bringing Treasury Reserve to $9.6 Million in Aggregate Purchases

    SINGAPORE , July 23, 2025 /PRNewswire/ -- Lion Group Holding Ltd. (NASDAQ:LGHL) ("LGHL" or the "Company") today announced that the Company has acquired additional SUI tokens, bringing the total combined purchase price of its HYPE, SOL and SUI holdings to approximately $9.6 million. These tokens form a core part of LGHL's strategic treasury reserve dedicated to next-generation Layer-1 blockchain ecosystems. As of July 23, 2025, LGHL's treasury holdings include: Hyperliquid (HYPE): 128,929 tokensSolana (SOL): 6,629 tokensSui (SUI): 1,015,680 tokensLGHL remains committed to exploring strategic opportunities within the digital asset space and will provide periodic updates as it continues to gro

    7/23/25 8:30:00 AM ET
    $LGHL
    Investment Bankers/Brokers/Service
    Finance

    VivoPower Confirms Record Date for Special Dividend Eligibility for Caret Digital Spin Off

    Shareholders on record as of July 9, 2025, to receive five Caret Digital shares per VVPR share held Caret Digital subsidiary is to be spun off via a direct NASDAQ IPO at a target market capitalisation of US$308 million Negotiations are progressing with strategic pre-IPO investors in the Middle East and Asia for investment of up to US$50 million LONDON, June 24, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ:VVPR, "VivoPower" or the "Company")) today announced that it has set the record date as July 9, 2025, for the purpose of determining eligibility to receive a special dividend relating to the spin-off of Caret Digital Limited ("Caret"). The implied market capitalisation

    6/24/25 3:30:00 PM ET
    $VVPR
    Power Generation
    Utilities

    VivoPower Sets Record Date for Special Dividend Distributions Relating to Tembo Transactions

    Shareholders as at the ex-dividend date of 12 June 2025 will be eligible to receive any potential special dividend distributions relating to Tembo transactions  Corresponding record date will be 13 June 2025 LONDON, June 09, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ:VVPR, "VivoPower" or the "Company")) today announced that it has set an ex-dividend date of 12 June 2025 pertaining to any potential future dividend distributions regarding transactions involving Tembo e LV B.V. ("Tembo"). Shareholders who hold VivoPower shares as of the close of business on 12 June 2025 will be entitled to receive any potential future special dividend distributions relating to Tembo. Shar

    6/9/25 10:03:00 AM ET
    $VVPR
    Power Generation
    Utilities